Biogen CEO says he’s concerned about ‘a lot more policy risk’ in D.C.
Running a biotech company means taking risks — deciding where to invest, for example, or what scientific targets to chase. ...
Running a biotech company means taking risks — deciding where to invest, for example, or what scientific targets to chase. ...
SAN FRANCISCO — Biogen would like to make additional biotech acquisitions in 2025 beyond Friday’s offer to buy its financially ...
An Ionis Pharmaceuticals drug in development for Angelman syndrome has mid-stage clinical trial results showing improvement across a range of ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.